Validation of a  self-administered olfactory and gustatory test for the remotely evaluatio

Thirty-three home-quarantined COVID-19 patients underwent a self-administered chemosensitive test and an operator-administered test. The results, validated by Luigi Angelo Vaira of the University of Sassari, showed no significant difference between the two testing methods. This suggests the self-administered test can provide objective data on chemosensitive disorders in COVID-19 patients.

Use Cases

• Validating remote self-assessment tools for COVID-19 symptoms based on olfactory and gustatory test results.
• Comparing patient-reported outcomes with clinician-administered tests based on the described validation study.
• Analyzing the prevalence and severity of chemosensitive disorders in paucisymptomatic COVID-19 cases based on the study's focus.

Strengths

• Validation against operator-administered tests showed no significant difference (P = 0.201 for olfaction, P = 0.180 for taste).
• Focus on a specific, clinically relevant population: 33 home-quarantined COVID-19 patients.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

University of Sassari

Collection Method

Clinical study comparing self-administered and operator-administered chemosensitive tests.